Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Neurocrine
>
Interesting Read!
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6325026"]In the article, it said Eric Benevich (executive #4) was the architect of basically all the wrongdoings by Avanir. He jumps ship in 2015 and goes over to Neurocrine as their #3 in command and brings the entire team with him. Several of these recruits get indicted by the feds as well as several of the docs they use to write the majority of their prescriptions who are also the largest recipients of speaker fees. </p><p><br /></p><p>How could Kevin Gorman, who is CEO of Neurocrine and also a PhD, not see the problem with this. Isn't this basically bringing a contagion into the Neurocrine ecosystem? Ingrezza sales could not have been THAT important to them. Why have they not preemptively cleaned house? Why aren't they disclosing to shareholders that several Avanir wrongdoers worked their way in to the Salesforce's, and then assuring said shareholders that the issue has been addressed? This is a ticking time bomb that, if it gets out in the wrong way, will effect share price and profitability. What the heck is going on here?[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6325026"]In the article, it said Eric Benevich (executive #4) was the architect of basically all the wrongdoings by Avanir. He jumps ship in 2015 and goes over to Neurocrine as their #3 in command and brings the entire team with him. Several of these recruits get indicted by the feds as well as several of the docs they use to write the majority of their prescriptions who are also the largest recipients of speaker fees. How could Kevin Gorman, who is CEO of Neurocrine and also a PhD, not see the problem with this. Isn't this basically bringing a contagion into the Neurocrine ecosystem? Ingrezza sales could not have been THAT important to them. Why have they not preemptively cleaned house? Why aren't they disclosing to shareholders that several Avanir wrongdoers worked their way in to the Salesforce's, and then assuring said shareholders that the issue has been addressed? This is a ticking time bomb that, if it gets out in the wrong way, will effect share price and profitability. What the heck is going on here?[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Neurocrine
>
Interesting Read!
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Neurocrine
>
Interesting Read!
>